The incidence and mortality from melanoma continue to rise worldwide. Unfortunately, there is still no consistently effective treatment for metastatic disease. The fact that survival for melanoma has increased dramatically over the last 30 years highlights the importance of early detection of this malignancy.
Conclusion:
With continued public education and the advent of new technologies, it is hoped that we will be able to improve on what has been accomplished to date to reduce the health burden of melanoma even further. This article reviews issues related to patient and physician detection of melanoma and highlights newer technologies being used for this purpose.
Get full access to this article
View all access options for this article.
References
1.
MackieRMBrayCAVesteyJ. Melanoma incidence and mortality in Scotland 1979–2003. Br J Cancer2007;96:1772–7.
2.
GellerACSwetterSMBrooksK. Screening early detection, and trends for melanoma: Current status (2000–2006) and future directions. J Am Acad Dermatol2007;57:555–72.
3.
MackieRMBrayCAHoleDJ. Incidence and survival from malignant melanoma in Scotland: An epidemiological study. Lancet2002;360:587–91.
4.
MoloneyFJComberHO'LorcainP. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol2006;155:857–8.
5.
GarbeCEigentlerTK. Diagnosis and treatment of cutaneous melanoma: State of the art 2006. Melanoma Res2007;17:117–27.
6.
RichardMAGrabJJAvrilMF. Delays in diagnosis and melanoma prognosis (I): The role of patients. Int J Cancer2000;89: 271–9.
7.
TylerIRiversJKShovellerJABlumA. Melanoma detection in British Columbia, Canada. J Am Acad Dermatol2005;52:48–54.
8.
MartinRAWeinstockMARisicaPM. Factors associated with thorough skin self-examination for the early detection of melanoma. J Eur Acad Dermatol Venereol2007;21:1074–81.
9.
RobinsonJKTurrisiRStapletonJ. Examination of mediating variables in a partner assistance intervention designed to increase performance of skin self-examination. J Am Acad Dermatol2007;56:391–7.
10.
FriedmanRJRigelDSKopfAW. Early detection of malignant melanoma: The role of physician examination and self-examination of the skin. CA Cancer J Clin1985;35:130–51.
11.
HealsmithMFBourkeJFOsbourneJEGraham-BrownRA. An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma. Br J Dermatol1994;130:48–50.
12.
AbbasiNRShawHMRigelDS. Early diagnosis of cutaneous melanoma: Revisiting the ABCD criteria. JAMA2004;292:2771–6.
13.
AbbasiNRYancovitzMGutkowicz-KrusinD. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Arch Dermatol2008;144:469–74.
14.
ScopeADussaSWHalpernAC. The “ugly duckling” sign: Agreement between observers. Arch Dermatol2008;1444:58–64.
15.
GirardiSGaudyCGouvernetJ. Superiority of a cognitive education with photographs over ABCD critieria in the education of the general population to the early detection of melanoma: A randomized study. Int J Cancer2006;118:2276–80.
16.
SwetterSMJohnsonTMMillerDR. Melanoma in middleaged and older men: A multi-institutional survey study of factors related to tumor thickness. Arch Dermatol2010;145:397–404.
17.
PennieMLSeaverLSRisserJB. Melanoma outcomes for Medicare patients. Arch Dermatol2007;143:488–94.
18.
CarliPDe GiorgiVBettiR. Relationship between cause of referral and diagnostic outcome in pigmented lesion clinics: A multicentre survey of the Italian Multidisciplinary Group on Melanoma (GIPMe). Melanoma Res2003;13:207–11.
19.
WeatherheadSCLawrenceCM. Melanoma screening clinics: Are we detecting more melanomas or reasurring the worried well?Br J Dermatol2006;154:539–41.
20.
GoldbergMSDoucetteJTLimHW. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001–2005. J Am Acad Dermatol2007;57:60–6.
21.
GellerACSoberAJZhangZ. Strategies for improving melanoma education and screening for men age > 50 years. Cancer2002;95:1554–61.
22.
KohHKNortonLAGellerAC. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. J Am Acad Dermatol1996;34:971–8.
23.
AitkenJKYoulPHJandaM. Increase in skin cancer screening during a community-base randomized intervention trial. Int J Cancer2006;118:1010–6.
24.
BlumAIngvarCAvramidisM. Time to diagnosis of malignant melanoma: Same trends in different continents. J Cutan Med Surg2007;11:137–44.
25.
WitheilerDDCockerellCJ. Histologic features and sensitivity of diagnosis of clinically unsuspected cutaneous melanoma. Am J Dermatopathol1991;13:551–6.
26.
LindelofBHedbladMA. Accuracy in the clinical diagosis and pattern of malignant melanoma of a dermatological clinic. J Dermatol1994;21:461–4.
27.
SlueWKopfAWRiversJK. Total-body photographs of dysplastic nevi. Arch Dermatol1988;124:1239–43.
28.
RiversJKKopfAWVinokurAF. Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi. Cancer1990;65:1232–6.
29.
WangSQKopfAWKoenigK. Detection of melanoma in patients followed up with total cutaneous photography and dermoscopy. J Am Acad Dermatol2004;50:15–20.
30.
HalpernA. Total body skin imaging as an aid to melanoma detection. Semin Cutan Med Surg2003;22:2–8.
31.
FeitNEDuszaSWMarghoobAA. Melanomas detected with the aid of total cutaneous photography. Br J Dermatol2004;150:706–14.
32.
RisserJPressleyZVeledarE. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic. J Am Acad Dermatol2007;57:428–34.
33.
KittlerHPehambergerHWolffKBinderM. Diagnostic accuracy of dermoscopy. Lancet Oncol2002;3:159–65.
34.
ArgenzianoGSoyerHPChimentiS. Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet. J Am Acad Dermatol2003;48:679–93.
35.
CarliPQuercioloiESestiniS. Pattern analysis, not simplified algorithms, is the most reliable method for teaching dermoscopy for melanoma diagnosis to residents in dermatology. Br J Dermatol2003;148:981–4.
36.
PagnanelliGSoyerHPArgenzianoG. Diagnosis of pigmented skin lesions by dermoscopy: Web-based training improves diagnostic performance of non-experts. Br J Dermatol2003;148:698–702.
37.
TrippJMKopfAWMarghoobAABartRS. Management of dysplastic nevi: A survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol2002;46:674–82.
38.
GutenevASkladnevVNVarvelD. Acquisition-time image quality control in digital dermoscopy of skin lesions. Comput Med Imaging Graph2001;25:495–9.
39.
WollinaUBurroniMTorricelliR. Digital dermoscopy in a clinical practice: A three-centre analysis. Skin Res Technol2007;13: 133–42.
40.
KittlerHPehambergerHWolffKBinderM. Follow-up of melanocytic skin lesions with a digital epiluminescence microscopy: Patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Dermatol2000;43:467–76.
41.
PiccoloDFerrariAPerisK. Dermoscopic diagnosis by a trained clinician vs. a clinician with a minimal dermoscopy training vs. computer aided diagnosis of 341 pigmented skin lesions: A comparative study. Br J Dermatol2002;147:481–6.
42.
RosadoBMenziesSHarbauerA. Accuracy of computer diagnosis of melanoma: A quantitative meta-analysis. Arch Dermatol2004;140:363–4.
43.
PerrinaudAGaideOFrenchLE. Can automated dermoscopy image analysis instruments provide added benefits for the dermatologist? A study comparing the results of three systems. Br J Dermatol2007;157:926–33.
44.
ElbaumMEKopfAWRabinovitzHS. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: A feasibility study. J Am Acad Dermatol2001;44:207–18.
45.
FreidmanRJGutkowicz-KrusinDFarderMJ. The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. Arch Dermatol2008;144:476–82.
46.
TehraniHWallsJCottonS. Spectrophotometric intracutaneous analysis in the diagnosis of basal cell carcinoma: A pilot study. Int J Dermatol2007;46:371–5.
47.
MoncrieffMCottonSClaridgeEHallP. Spectrophotometric intracutaneous analysis: A new technique for imaging pigmented skin lesions. Br J Dermatol2002;146:448–57.
48.
GovindanKSmithJKnowlesL. Assessment of a nurse-led screening of pigmented skin lesions using SIAscope. J Plast Reconstr Aesthet Surg2007;60:639–45.
49.
HaniffaMALloydJJLawrenceCM. The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic. Br J Dermatol2007;156:1350–2.
50.
MarghoobAASwindleLDMoriczCZM. Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol2003;49:777–97.
51.
GambichlerTRegeniterPBecharaFG. Characterization of benign and malignant melanocytic skin lesions using optical coherence tomography in vivo. J Am Acad Dermatol2007;57:629–37.
52.
PellacaniGCesinaroAMGranaCSeidenariS. In vivo confocal scanning laser microscopy of pigmented Spitz nevi: Comparison of in vivo confocal images with dermoscopy and routine histopathology. J Am Acad Dermatol2004;51:371–6.
53.
LangleyRGBWalshNSutherlandAE. The diagnostic accuracy of in vivo confocal laser microscopy compared to dermoscopy of benign and malignant melanocytic lesions: A prospective study. Dermatology2007;215:365–72.
